Jie Fu
- Molecular Biology top 10%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Surgery
- Topics
- Endometrial and Cervical Cancer Treatments (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)Lung Cancer Treatments and Mutations (7 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jie Fu
94 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 139
- Molecular Biology 741
- Oncology 371
- Pulmonary and Respiratory Medicine 256
- Cancer Research 205
- Surgery 107
Countries citing papers authored by Jie Fu
This map shows the geographic impact of Jie Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Fu more than expected).
Fields of papers citing papers by Jie Fu
This network shows the impact of papers produced by Jie Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Fu. The network helps show where Jie Fu may publish in the future.
Co-authorship network of co-authors of Jie Fu
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Fu. A scholar is included among the top collaborators of Jie Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Fu. Jie Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 6 | |
| 13 | 6 | |
| 14 | 4 | |
| 15 | 7 | |
| 16 | 38 | |
| 17 | 12 | |
| 18 | 9 | |
| 19 | 7 | |
| 20 | 12 |
About Jie Fu
Jie Fu is a scholar working on Obstetrics and Gynecology, Otorhinolaryngology and Internal Medicine, having authored 99 papers that have together received 1.5k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Cancer Research (205 citations), Oncology (371 citations) and Molecular Biology (741 citations). Jie Fu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Hexin Chen, Jing Li, Heng Zheng, Walden Ai, Shiang Huang, Swapan K. Ray, Xiaojing Yang, Hanru Ren, Yangmei Chen and Lilei Peng. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.